First in vivo base-editing trial shows promise.
Mol Ther
; 32(1): 1-2, 2024 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-38104562
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CRISPR-Cas Systems
/
Gene Editing
Language:
En
Journal:
Mol Ther
Journal subject:
BIOLOGIA MOLECULAR
/
TERAPEUTICA
Year:
2024
Document type:
Article
Country of publication:
United States